Atossa Therapeutics, Inc. (ATOS) SEC filings
ATOS SEC filings moved a median of -1.57% by the close. ATOS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ATOS overview →
68 measured ATOS SEC filing events.
Where these ATOS SEC filings landedvs 66 measured ATOS SEC filing reactions
| Middle 50% of ATOS SEC filing reactions | -4.40% to +2.16% |
|---|---|
| Median reaction (to close) | -1.57% |
| Measured reactions | 66 |
Point-in-time · zero look-ahead
Half of the 66 ATOS SEC filing events with a measured close landed between -4.40% and +2.16%; 38% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K ATOSSA THERAPEUTICS, For: Oct 08 | SEC filing · Form 8-K | +0.00% | -0.41% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Sep 29 | SEC filing · Form 8-K | +1.94% | -3.40% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Sep 18 | SEC filing · Form 8-K | +1.33% | +0.00% | |
| Form 10-Q ATOSSA THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | -0.30% | -0.42% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Aug 07 | SEC filing · Form 8-K | -0.30% | -0.42% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Jun 10 | SEC filing · Form 8-K | -5.80% | -6.34% | |
| Form 10-Q ATOSSA THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +0.55% | +3.32% | |
| Form 8-K ATOSSA THERAPEUTICS, For: May 07 | SEC filing · Form 8-K | +0.55% | +3.32% | |
| Form 8-K ATOSSA THERAPEUTICS, For: May 08 | SEC filing · Form 8-K | +0.55% | +3.32% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Apr 13 | SEC filing · Form 8-K | -0.22% | +2.31% | |
| Form ARS ATOSSA THERAPEUTICS, For: Dec 31 | SEC filing · Form ARS | +6.50% | +10.27% | |
| Form DEF 14A ATOSSA THERAPEUTICS, For: Mar 30 | SEC filing · Form DEF | +6.50% | +10.27% | |
| Form 10-K ATOSSA THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | +1.16% | -9.25% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Mar 25 | SEC filing · Form 8-K | +1.16% | -9.25% | |
| Form PRE 14A ATOSSA THERAPEUTICS, For: Mar 20 | SEC filing · Form PRE | +0.74% | +4.47% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Feb 19 | SEC filing · Form 8-K | +0.00% | -3.65% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Feb 17 | SEC filing · Form 8-K | +0.98% | +6.90% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Feb 11 | SEC filing · Form 8-K | -3.15% | -14.92% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Jan 20 | SEC filing · Form 8-K | -2.09% | +8.21% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Jan 09 | SEC filing · Form 8-K | +0.38% | -2.26% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Jan 06 | SEC filing · Form 8-K | +2.63% | +8.26% | |
| Form DEF 14A ATOSSA THERAPEUTICS, For: Dec 19 | SEC filing · Form DEF | -1.57% | -2.02% | |
| Form PRE 14A ATOSSA THERAPEUTICS, For: Dec 12 | SEC filing · Form PRE | -1.34% | -3.42% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Dec 04 | SEC filing · Form 8-K | +0.23% | +2.25% | |
| Form 10-Q ATOSSA THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | -0.21% | -1.74% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Nov 12 | SEC filing · Form 8-K | -0.21% | -1.74% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Oct 14 | SEC filing · Form 8-K | +0.00% | +0.98% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Sep 26 | SEC filing · Form 8-K | +2.19% | +1.36% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Sep 08 | SEC filing · Form 8-K | -0.75% | +1.39% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Aug 21 | SEC filing · Form 8-K | -2.00% | +2.30% | |
| Form 10-Q ATOSSA THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | +0.41% | — | |
| Form 8-K ATOSSA THERAPEUTICS, For: Aug 12 | SEC filing · Form 8-K | +0.41% | — | |
| Form 10-Q ATOSSA THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | -2.03% | +2.30% | |
| Form 8-K ATOSSA THERAPEUTICS, For: May 13 | SEC filing · Form 8-K | -2.03% | +2.30% | |
| Form 8-K ATOSSA THERAPEUTICS, For: May 08 | SEC filing · Form 8-K | -1.28% | -2.69% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Apr 07 | SEC filing · Form 8-K | +1.43% | -11.30% | |
| Form ARS ATOSSA THERAPEUTICS, For: Dec 31 | SEC filing · Form ARS | -0.15% | -2.97% | |
| Form DEF 14A ATOSSA THERAPEUTICS, For: Mar 26 | SEC filing · Form DEF | -0.15% | -2.97% | |
| Form S-8 ATOSSA THERAPEUTICS, | SEC filing · Form S-8 | -0.15% | -2.97% | |
| Form 10-K ATOSSA THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | -2.09% | -6.00% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Mar 25 | SEC filing · Form 8-K | -2.09% | -6.00% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Mar 11 | SEC filing · Form 8-K | -1.75% | -3.19% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Feb 21 | SEC filing · Form 8-K | -0.06% | -4.53% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Jan 30 | SEC filing · Form 8-K | +0.53% | -2.67% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Dec 10 | SEC filing · Form 8-K | -0.20% | -0.79% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Nov 19 | SEC filing · Form 8-K | -3.03% | -4.00% | |
| Form 10-Q ATOSSA THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | -0.31% | -6.25% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Nov 12 | SEC filing · Form 8-K | -3.70% | -7.41% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Nov 04 | SEC filing · Form 8-K | -4.19% | -1.40% | |
| Form 10-Q ATOSSA THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | +0.82% | +1.64% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Aug 12 | SEC filing · Form 8-K | +0.82% | +1.64% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Jun 27 | SEC filing · Form 8-K | +0.44% | +2.63% | |
| Form EFFECT ATOSSA THERAPEUTICS, | SEC filing · Form EFFECT | -2.04% | +0.00% | |
| Form DEF 14A ATOSSA THERAPEUTICS, For: May 23 | SEC filing · Form DEF | -1.28% | -5.81% | |
| Form DEL AM ATOSSA THERAPEUTICS, | SEC filing · Form DEL | +6.96% | +1.90% | |
| Form 10-Q ATOSSA THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +1.38% | +0.69% | |
| Form 8-K ATOSSA THERAPEUTICS, For: May 13 | SEC filing · Form 8-K | +1.38% | +0.69% | |
| Form S-3 ATOSSA THERAPEUTICS, | SEC filing · Form S-3 | +3.85% | +7.69% | |
| Form ARS ATOSSA THERAPEUTICS, For: Dec 31 | SEC filing · Form ARS | +1.19% | -11.83% | |
| Form PRE 14A ATOSSA THERAPEUTICS, For: May 10 | SEC filing · Form PRE | +1.19% | -11.83% | |
| Form 8-K/A ATOSSA THERAPEUTICS, For: Apr 01 | SEC filing · Form 8-K | -2.04% | -8.00% | |
| Form 10-K ATOSSA THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | -2.04% | -8.00% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Apr 01 | SEC filing · Form 8-K | -2.04% | -8.00% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Mar 15 | SEC filing · Form 8-K | -2.33% | +0.00% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Mar 09 | SEC filing · Form 8-K | +3.25% | +6.50% | |
| Form 10-Q ATOSSA THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | +3.22% | -2.74% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Nov 13 | SEC filing · Form 8-K | +3.22% | -2.74% | |
| Form 8-K ATOSSA THERAPEUTICS, For: Nov 09 | SEC filing · Form 8-K | -0.48% | -6.49% |
Keep exploring
More ATOS: earnings → · analyst actions → · ATOS overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| EKIMAS CORPORATION (ASNB) | 223 | 0.00% | 45% |
| OASMIA PHARMACEUTICALS AB AMERICAN DEPOSITARY SHARE (OASM) | 223 | 0.00% | 35% |
| FibroGen, Inc (FGEN) | 220 | -0.50% | 45% |
| INNOVATE BIOPHARMACEUTICALS (INNT) | 220 | -0.77% | 38% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.